Apr 28, 2026 09:02AM
Apr 28, 2026 09:01AM
Jan 13, 2026 09:15AM
Jan 13, 2026 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 2, 2025 09:15AM Creative Medical receives WHO approval for olastrocel drug name
Dec 2, 2025 09:15AM
Oct 27, 2025 08:15AM
Oct 27, 2025 08:15AM
Aug 13, 2025 09:01AM
Aug 13, 2025 09:01AM
Mar 20, 2025 07:50AM
Mar 20, 2025 07:50AM Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
Feb 20, 2025 08:00AM
Feb 14, 2025 07:00AM
Feb 11, 2025 09:25AM
Feb 11, 2025 09:25AM
Nov 13, 2024 09:01AM
Nov 13, 2024 09:00AM
Jul 24, 2024 09:03AM Creative Medical Technology (CELZ) Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure
Jul 24, 2024 09:00AM
Jul 10, 2024 08:32AM
Jul 10, 2024 08:30AM
Jun 24, 2024 08:30AM
Mar 27, 2024 09:00AM
Mar 7, 2024 09:15AM
Mar 7, 2024 09:15AM Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Mar 6, 2024 07:00AM
Mar 6, 2024 07:00AM
Dec 20, 2023 09:38AM
Dec 20, 2023 09:33AM
Nov 15, 2023 08:00AM
Oct 10, 2023 08:00AM
Sep 19, 2023 08:01AM Creative Medical Technology Holdings (CELZ) Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine using AlloStem
Sep 19, 2023 08:00AM
Aug 24, 2023 10:45AM
Jul 13, 2023 09:00AM
Jun 12, 2023 08:00AM
Jun 12, 2023 08:00AM
Apr 12, 2023 08:01AM
Apr 12, 2023 08:00AM Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Apr 4, 2023 08:00AM
Mar 23, 2023 08:00AM
Mar 7, 2023 08:07AM
Mar 7, 2023 08:00AM
Feb 8, 2023 08:00AM
Feb 8, 2023 08:00AM
Nov 3, 2022 07:31AM Creative Medical (CELZ) Announces FDA Clearance of Investigational New Drug Application for AlloStem, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
Nov 3, 2022 07:30AM

323,583 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All